{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:19:42Z","timestamp":1762867182429},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","trasci.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.transci.2017.07.010","type":"journal-article","created":{"date-parts":[[2017,7,9]],"date-time":"2017-07-09T00:45:39Z","timestamp":1499561139000},"page":"525-530","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Plasma exchange in kidney transplantation: Still a valuable option for nephrotic syndrome recurrence"],"prefix":"10.1016","volume":"56","author":[{"given":"Licia","family":"Peruzzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Albiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karol","family":"Giancaspero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"August (8)","key":"10.1016\/j.transci.2017.07.010_bib0005","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00467-013-2509-5","article-title":"Late steroid resistance in childhood nephrotic syndrome: do we now know more than 40 years ago?","volume":"28","author":"Akchurin","year":"2013","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.transci.2017.07.010_bib0010","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.kint.2016.12.032","article-title":"Keeping the customers stratified: moving toward genetics-based treatment options in childhood NS","volume":"91","author":"Puckelwartz","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.transci.2017.07.010_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2016.10.013","article-title":"Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management","author":"Bierzynska","year":"2017","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.transci.2017.07.010_bib0020","first-page":"33","article-title":"Tacrolimus in steroid resistant and steroid dependent childhood nephrotic syndrome","volume":"96","author":"Supavekin","year":"2013","journal-title":"J Med Assoc Thail"},{"issue":"1","key":"10.1016\/j.transci.2017.07.010_bib0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00467-006-0294-0","article-title":"A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome","volume":"22","author":"Fujinaga","year":"2007","journal-title":"Ped Nephrol (Berlin, Germany)"},{"issue":"July (1)","key":"10.1016\/j.transci.2017.07.010_bib0030","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1542\/peds.2015-0486","article-title":"Mycophenolate mofetil following rituximab in children with steroid-resistant nephrotic syndrome","volume":"136","author":"Basu","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.transci.2017.07.010_bib0035","doi-asserted-by":"crossref","DOI":"10.1038\/ki.2013.211","article-title":"Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome","author":"Ravani","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.transci.2017.07.010_bib0040","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2013080852","article-title":"Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence","author":"Ding","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.transci.2017.07.010_bib0045","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4132\/jptm.2016.09.21","article-title":"Pathogenesis of focal segmental glomerulosclerosis","volume":"50","author":"Lim","year":"2016","journal-title":"J Pathol Transl Med"},{"key":"10.1016\/j.transci.2017.07.010_bib0050","series-title":"Causes and pathogenesis of focal segmental glomerulosclerosis","author":"Fogo","year":"2017"},{"issue":"January","key":"10.1016\/j.transci.2017.07.010_bib0055","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000348637","article-title":"Different targets for treating focal segmental glomerular sclerosis","volume":"181","author":"Coppo","year":"2013","journal-title":"Contrib Nephrol"},{"issue":"5","key":"10.1016\/j.transci.2017.07.010_bib0060","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/MOT.0b013e32833dee3a","article-title":"Recurrence of focal segmental glomerulosclerosis after kidney transplantation: strategies and outcome","volume":"15","author":"Ulinski","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"issue":"2","key":"10.1016\/j.transci.2017.07.010_bib0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00467-015-3082-x","article-title":"The glomerular permeability factors in idiopathic nephrotic syndrome","volume":"31","author":"Davin","year":"2016","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"10.1016\/j.transci.2017.07.010_bib0070","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/ndt\/gfu355","article-title":"Permeability factors in idiopathic nephrotic syndrome: historical perspectives and lessons for the future","volume":"29","author":"Maas","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"February (1)","key":"10.1016\/j.transci.2017.07.010_bib0075","first-page":"37","article-title":"A vascular permeability factor elaborated from lymphocytes. I. Demonstration in patients with nephrotic syndrome","volume":"23","author":"Lagrue","year":"1975","journal-title":"Biomedicine"},{"issue":"5","key":"10.1016\/j.transci.2017.07.010_bib0080","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1681\/ASN.2006070710","article-title":"Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats","volume":"18","author":"Lai","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"December (12)","key":"10.1016\/j.transci.2017.07.010_bib0085","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1007\/s00467-012-2163-3","article-title":"TNF\u03b1 pathway blockade ameliorates toxic effects of FSGS plasma on podocyte cytoskeleton and \u03b23 integrin activation","volume":"27","author":"Bitzan","year":"2012","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.transci.2017.07.010_bib0090","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1681\/ASN.2013030251","article-title":"Rituximab in nephrotic syndrome of steroid-dependent or frequently relapsing minimal change disease or focal segmental glomerulosclerosis (NEMO) study group. Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome","volume":"25","author":"Ruggenenti","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.transci.2017.07.010_bib0095","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1053\/j.ajkd.2009.06.010","article-title":"PLasma \u2018factors\u2019 in recurrent nephrotic syndrome after kidney transplantation: causes or consequences of glomerular injury?","volume":"54","author":"Savin","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.transci.2017.07.010_bib0100","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.2215\/CJN.03800609","article-title":"Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis","volume":"5","author":"McCarthy","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.transci.2017.07.010_bib0105","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1007\/s00467-005-1936-3","article-title":"Altered activity of plasma hemopexin in patients with minimal change disease in relapse","volume":"20","author":"Bakker","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.transci.2017.07.010_bib0110","series-title":"Serum suPAR in patients with FSGS: trash or treasure?","author":"Maas","year":"2017"},{"key":"10.1016\/j.transci.2017.07.010_bib0115","series-title":"Circulating permeability factors in primary focal segmental glomerulosclerosis: a review of proposed candidates","author":"K\u00f6nigshausen","year":"2017"},{"issue":"December (6)","key":"10.1016\/j.transci.2017.07.010_bib0120","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/ckj\/sfv090","article-title":"A circulating permeability factor in focal segmental glomerulosclerosis: the hunt continues","volume":"8","author":"Wada","year":"2015","journal-title":"Clin Kidney J"},{"issue":"December","key":"10.1016\/j.transci.2017.07.010_bib0125","article-title":"Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease","author":"Hahm","year":"2016","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.transci.2017.07.010_bib0130","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000183469","article-title":"Plasmapheresis and dipyridamole for recurrent focal glomerular sclerosis","volume":"40","author":"Zimmerman","year":"1985","journal-title":"Nephron"},{"issue":"Suppl 3","key":"10.1016\/j.transci.2017.07.010_bib0135","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","author":"Bromberg","year":"2009","journal-title":"Am J Transplant Off J Am Soc Trabspl Am Soc Transpl Surg"},{"issue":"January (1)","key":"10.1016\/j.transci.2017.07.010_bib0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/ndt\/gfp538","article-title":"Recurrence of focal segmental glomerular sclerosis (FSGS) after renal transplantation","volume":"25","author":"Ponticelli","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.transci.2017.07.010_bib0145","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1111\/j.1600-6143.2005.01112.x","article-title":"Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients","volume":"5","author":"Gohh","year":"2005","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.transci.2017.07.010_bib0150","doi-asserted-by":"crossref","first-page":"E286","DOI":"10.1111\/j.1399-3046.2011.01610.x","article-title":"Pretransplantation combined therapy with plasmapheresis and rituximab in a second living-related kidney transplant pediatric recipient with a very high risk for focal segmental glomerulosclerosis recurrence","volume":"16","author":"Chikamoto","year":"2012","journal-title":"Pediatr Transplant"},{"issue":"5","key":"10.1016\/j.transci.2017.07.010_bib0155","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1600-6143.2009.02580.x","article-title":"Intensive and prolonged treatment of focal and segmental glomerulosclerosis recurrence in adult kidney transplant recipients: a pilot study","volume":"9","author":"Canaud","year":"2009","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.transci.2017.07.010_bib0160","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12882-016-0322-7","article-title":"The role of plasma exchange in treating post-transplant focal segmental glomerulosclerosis: a systematic review and meta-analysis of 77 case-reports and case-series","volume":"17","author":"Kashgary","year":"2016","journal-title":"BMC Nephrol"},{"issue":"256","key":"10.1016\/j.transci.2017.07.010_bib0165","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008538","article-title":"A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation","volume":"6","author":"Delville","year":"2014","journal-title":"Sci Transl Med"},{"issue":"85","key":"10.1016\/j.transci.2017.07.010_bib0170","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002231","article-title":"Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis","volume":"3","author":"Fornoni","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.transci.2017.07.010_bib0175","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1681\/ASN.2013121331","article-title":"Rituximab: a boot to protect the foot","author":"Reiser","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.transci.2017.07.010_bib0180","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/TP.0000000000001160","article-title":"Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation","volume":"101","author":"Garrouste","year":"2017","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.transci.2017.07.010_bib0185","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1681\/ASN.2013040363","article-title":"Rituximab treatment prevents the early development of proteinuria following pig-to-baboon xeno-kidney transplantation","volume":"25","author":"Tasaki","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"July (6)","key":"10.1016\/j.transci.2017.07.010_bib0190","first-page":"166","article-title":"Plasma removal with return of corpuscles (plasmaphaeresis)","volume":"V","author":"Abel","year":"1914","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.transci.2017.07.010_bib0195","first-page":"149","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the american society for apheresis: the seventh special issue","volume":"31","author":"Schwartz","year":"2016","journal-title":"J Clin Apher"},{"issue":"6","key":"10.1016\/j.transci.2017.07.010_bib0200","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1526-0968.2001.00386.x","article-title":"Plasmapheresis affects T helper type-1\/T helper type-2 balance of circulating peripheral lymphocytes","volume":"5","author":"Goto","year":"2001","journal-title":"Ther Apher: Off J Int Soc Apher Japan Soc Apher"},{"issue":"December (6)","key":"10.1016\/j.transci.2017.07.010_bib0205","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1046\/j.1526-0968.2002.00466.x","article-title":"Miller Fisher syndrome and plasmapheresis","volume":"6","author":"Kambara","year":"2002","journal-title":"Ther Apher"},{"issue":"June (2)","key":"10.1016\/j.transci.2017.07.010_bib0210","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ajh.20342","article-title":"Effect of plasma exchange on cytokines measured by multianalyte bead array in thrombotic thrombocytopenic purpura","volume":"79","author":"Shariatmadar","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.transci.2017.07.010_bib0215","series-title":"Apheresis Principles and Practice, Current instrumentation for apheresis","year":"2010"},{"issue":"September (3)","key":"10.1016\/j.transci.2017.07.010_bib0220","first-page":"346","article-title":"The efficacy of plasma exchange in the removal of plasma components","volume":"104","author":"Derksen","year":"1984","journal-title":"J Lab Clin Med"},{"issue":"3","key":"10.1016\/j.transci.2017.07.010_bib0225","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jca.20240","article-title":"Apheresis applications committee of the american society for apheresis. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the apheresis applications committee of the american society for apheresis","volume":"25","author":"Szczepiorkowski","year":"2010","journal-title":"J Clin Apher"},{"issue":"September (3)","key":"10.1016\/j.transci.2017.07.010_bib0230","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1182\/blood.V54.3.694.694","article-title":"The hemostatic imbalance of plasma-exchange transfusion","volume":"54","author":"Flaum","year":"1979","journal-title":"Blood"},{"issue":"August (4)","key":"10.1016\/j.transci.2017.07.010_bib0235","first-page":"627","article-title":"Coagulation abnormalities following intensive plasma exchange on the cell separator. II. Effects on factors I, II, V, VII, VIII, IX, X and antithrombin III","volume":"48","author":"Chirnside","year":"1984","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.transci.2017.07.010_bib0240","first-page":"379","article-title":"Reasons why therapeutic apheresis should belong to nephrology","volume":"31","author":"Anaya Fern\u00e1ndez-Lomana","year":"2011","journal-title":"Nefrologia"},{"issue":"December (6)","key":"10.1016\/j.transci.2017.07.010_bib0245","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1182\/blood.V56.6.1055.1055","article-title":"Partial plasma exchange using albumin replacement: removal and recovery of normal plasma constituents","volume":"56","author":"Orlin","year":"1980","journal-title":"Blood"},{"key":"10.1016\/j.transci.2017.07.010_bib0250","doi-asserted-by":"crossref","unstructured":"Volkin RL, Starz TW, Winkelstein A, Shadduck RK, Lewis JH, Hasiba U, et al. Changes in coagulation factors, complement, immunoglobulins, and immune complex concentrations with plasma exchange. Transfusion (n.d.); 22(1): 54\u20138. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7064208.","DOI":"10.1046\/j.1537-2995.1982.22182154218.x"},{"issue":"1","key":"10.1016\/j.transci.2017.07.010_bib0255","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.beha.2005.01.004","article-title":"Therapeutic apheresis: use of human serum albumin, fresh frozen plasma and cryosupernatant plasma in therapeutic plasma exchange","volume":"19","author":"McLeod","year":"2006","journal-title":"Best Pract Res Clin Haematol"},{"issue":"May (5)","key":"10.1016\/j.transci.2017.07.010_bib0260","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1093\/ndt\/gfs035","article-title":"Saquinavir in steroid-dependent and \u2212resistant nephrotic syndrome: a pilot study","volume":"27","author":"Coppo","year":"2012","journal-title":"Nephrol Dial Transplant"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050217301386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050217301386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T21:25:51Z","timestamp":1602451551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050217301386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1473050217301386"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2017.07.010","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma exchange in kidney transplantation: Still a valuable option for nephrotic syndrome recurrence","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2017.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}